Medicine. Moving toward transparency of clinical trials. - Wikidata - awgldk - TriplyDB

Medicine. Moving toward transparency of clinical trials.

Medicine. Moving toward transparency of clinical trials.

http://www.wikidata.org/entity/Q33322703

about

Biosafety data as confidential business information.Social science. Promoting transparency in social science research.Outcome reporting among drug trials registered in ClinicalTrials.gov Next stop, don't block the doors: opening up access to clinical trials results Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)Guidelines for the Reporting of Treatment Trials for Alcohol Use Disorders From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology A machine learning approach to identify clinical trials involving nanodrugs and nanodevices from ClinicalTrials.gov Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals Towards exergaming commons: composing the exergame ontology for publishing open game data Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications Likelihood of Null Effects of Large NHLBI Clinical Trials Has Increased over Time Results and outcome reporting In ClinicalTrials.gov, what makes it happen?Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy Reporting "basic results" in ClinicalTrials.gov Regulating prescription drugs for patient safety: does Bill C-17 go far enough?Registration of observational studies: is it time?Result publication of Chinese trials in World Health Organization primary registries.The ClinicalTrials.gov results database--update and key issues How frequently do the results from completed US clinical trials enter the public domain?--A statistical analysis of the ClinicalTrials.gov database.A call for more transparency of registered clinical trials on endometriosis.Systematic identification of pharmacogenomics information from clinical trials.How transparent are migraine clinical trials? Repository of Registered Migraine Trials (RReMiT).Deficiencies in the transfer and availability of clinical trials evidence: a review of existing systems and standards.Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials.Rate of asthma trial outcomes reporting on ClinicalTrials.gov and in the published literature.Results availability for analgesic device, complex regional pain syndrome, and post-stroke pain trials: comparing the RReADS, RReACT, and RReMiT databases.Analysis of 473 US Head and Neck Cancer Trials (1996-2014): Trends, Gaps, and Opportunities.Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.Effect Sizes and Primary Outcomes in Large-Budget, Cardiovascular-Related Behavioral Randomized Controlled Trials Funded by NIH Since 1980.Publication and non-publication of drug trial results: a 10-year cohort of trials in Norwegian general practice.The Primary Care Research Object Model (PCROM): a computable information model for practice-based primary care research A network biology model of micronutrient related health.Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry.Manipulating In-House Designed Drug Databases For The Prediction of pH-Dependent Aqueous Drug Solubility.The Landscape of Clinical Trials Evaluating the Theranostic Role of PET Imaging in Oncology: Insights from an Analysis of ClinicalTrials.gov Database Evaluating oversight of human drugs and medical devices: a case study of the FDA and implications for nanobiotechnology.Systematic reviews and meta-analyses in the new age of transparency.

P2860

Q24288798-CF72889B-E030-45A7-BD00-83EEAE347136 Q24289118-F066463F-23BA-41C4-82D4-82D8711C5D0A Q24289273-1500924B-BFF3-493A-83C9-3B2B9EEF6403 Q24550614-B7F50AC0-D78B-4E5B-9B18-1ECDC41904D2 Q26771054-5B625E84-6AFD-48AA-B099-DF45DB12CAB0 Q26779440-18BA4778-F626-4232-B53B-BA0922C78AB8 Q26797522-A33B5727-ADCB-457B-88FA-30DE6EC84124 Q28396566-8E13DE7E-7EBD-41C9-A428-AD9BFFF7E0D7 Q28478742-FDA5F713-70D6-4923-A7E7-15BEB9C48753 Q28482475-BE380713-F36B-431D-AF3C-BC718C17C22A Q28535706-004F3E87-77FD-4E09-B391-E97ED8E6D3FE Q28601079-A1D09806-72ED-4924-A67B-2A2C08BF4892 Q28608557-41EC3C14-5FE8-444E-BA4C-D8DDC3EF6CCF Q28644044-223657F4-E689-4E29-9FD3-5E4DBF139FF6 Q28728487-F29DD88F-C2A3-4282-AB4A-C1FE5D4F0374 Q28744662-2A684861-2AFA-42FB-92EA-1A54BC599993 Q33479438-75A20D0D-AA99-4B35-9C3F-18291B700DBF Q33590650-AB68C8E1-459C-457C-A951-EE37AFB336E4 Q33636327-D81AEC17-7AC4-4985-BB24-40455E5F42C8 Q33697965-F1889B09-EADC-4D1F-B897-C3E62F0244ED Q33834724-D63A41EF-0214-4A8C-A6EF-0776B58CE167 Q33903992-CB3A572D-11FC-4E53-9112-A51EA5C79654 Q33917982-6CD44A5B-1A5A-43EB-8490-A98FAC7EC271 Q34252141-62878377-7838-416A-9A9F-98E8F0B323B7 Q34303798-842F186B-2376-422F-A39A-3CA659D85BA1 Q34402803-A3B6BFDD-8BA5-47B9-9ED2-50A87993BB46 Q34546127-2E26664F-C3D8-46F1-82BC-8C2AB0C83667 Q34664039-AED90BAD-6963-4B51-BDF0-6D06D5594679 Q34790930-ABC41B90-43CF-4C7D-BF1F-5CDF25AE2365 Q35844346-A74EB5F7-CE66-4F68-B276-20618E0F305B Q35906626-A2AF41E9-7A1B-4C35-8537-487D1268B5E2 Q36552536-594ACF47-0221-4113-BDAD-C98362CCE187 Q36819100-9DE93008-54F5-4BE2-9FA7-A340AB062B46 Q36858927-F5D5073A-2A57-4BCF-9FF8-56DF290C5444 Q37206355-945CF4C7-E418-4AA3-A218-252BE2BE0C98 Q37516720-CAAF8D69-4C97-453C-A2A0-6039FDB4902E Q37520109-C25353D5-9EBB-4637-A9CF-6EF916B49676 Q37541997-E083AF5C-CCE8-48FB-A98A-103497A36B23 Q37685264-1C830B47-7CD3-4347-B8C3-660256D418B0 Q37774549-26CD87B1-840F-496C-868A-C723CFC2E057

P2860

Medicine. Moving toward transparency of clinical trials.

http://www.wikidata.org/entity/Q33322703

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Medicine. Moving toward transparency of clinical trials.

@ast

Medicine. Moving toward transparency of clinical trials.

@en

Medicine. Moving toward transparency of clinical trials.

@nl

type

label

Medicine. Moving toward transparency of clinical trials.

@ast

Medicine. Moving toward transparency of clinical trials.

@en

Medicine. Moving toward transparency of clinical trials.

@nl

prefLabel

Medicine. Moving toward transparency of clinical trials.

@ast

Medicine. Moving toward transparency of clinical trials.

@en

Medicine. Moving toward transparency of clinical trials.

@nl

P1433

Q33322703-987C1A8C-BDFF-4F35-9427-57C9C5EADEC2

P1476

Q33322703-C33DFBE5-D4E0-47EA-B945-1F1866865921

P2093

Q33322703-608E2B4A-68E1-4A89-A16C-E0E5FED8A068

P2860

Q33322703-0B472213-D9A8-4B42-BBBB-E0CC4B89ADE8

Q33322703-1037432C-E7E7-43DA-900A-6797EDB7729C

Q33322703-32F3DB1C-3791-4352-85E9-C870E73059A6

Q33322703-35CEA2F2-348F-4364-B14B-A6933028074B

Q33322703-3A7B25DA-E00A-483B-B1C3-052F465AEBC0

Q33322703-3C7B8665-3EEA-47F9-8A40-C74C2BDC0269

Q33322703-3F051D6E-2496-441C-A02F-CD0CFCFCDCC3

Q33322703-69334A8B-546A-4981-B615-F3067EA13CE6

Q33322703-7A47D4AB-6AC6-4D92-AF86-5F534A1208B7

Q33322703-7BEFB0FA-81D8-4B88-8717-BAC26FDC3783

P304

Q33322703-6C34A79B-5BAB-45F4-AD2B-FCA019986CDF

P31

Q33322703-780C3409-10D3-44E0-B559-4258890BD0D7

P356

Q33322703-77D30009-D3A1-4CD5-B56F-DFE96DF9A421

P407

Q33322703-89EC15AF-1690-4699-8E36-EF2237808336

P433

Q33322703-5C443D46-A8B2-4BFD-8A7C-CFD48A48774F

P478

Q33322703-B1F0E7D6-E54C-4511-883C-B670B62F1CA9

P50

Q33322703-E78E3308-6B55-4118-925A-E2F8F7065263

P577

Q33322703-A034337F-8717-463C-9352-4F92985EAB29

P5875

Q33322703-FCAA307F-3C9D-4224-A69D-8ABAA79BC00D

P698

Q33322703-7A3228F5-205B-4E1B-98A4-2BFD22E61B20

P932

Q33322703-392F6289-A60A-421F-8698-3CCBF38D49DC

P356

SCIENCE.1153632

P1433

P1476

Medicine. Moving toward transparency of clinical trials.

@en

P2093

Tony Tse

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

Publication bias in clinical research

Trial registration: a great idea switches from ignored to irresistible.

Trial Registration at ClinicalTrials.gov between May and October 2005

Publishing clinical trial results: the future beckons.

Issues in the registration of clinical trials.

Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis.

Observational studies of drug safety--aprotinin and the absence of transparency.

Public health. Clinical trials results databases: unanswered questions.

P304

1340-1342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1153632

http://www.w3.org/2001/XMLSchema#string

P407

P433

5868

http://www.w3.org/2001/XMLSchema#string

P478

319

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5529790

http://www.w3.org/2001/XMLSchema#string

P698

18323436

http://www.w3.org/2001/XMLSchema#string

P932

2396952

http://www.w3.org/2001/XMLSchema#string